Common Contracts
4 similar Executive Change in Control Severance Benefits Agreement contracts by Onyx Pharmaceuticals Inc
AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • May 18th, 2011 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Change in Control Severance Benefits Agreement (the “Agreement”) is entered into as of May 18, 2011 (the “Effective Date”), between Kaye Foster-Cheek (“Executive”) and Onyx Pharmaceuticals, Inc. (the “Company”) and amends and restates the prior Executive Change in Control Severance Benefits Agreement between the Company and Executive dated September 30, 2010 (the “Original Date”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to a qualifying termination of employment in connection with a Change in Control. Certain capitalized terms used in this Agreement are defined in Article 5.
AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • May 18th, 2011 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Change in Control Severance Benefits Agreement (the “Agreement”) is entered into as of May 18, 2011 (the “Effective Date”), between Ted W. Love (“Executive”) and Onyx Pharmaceuticals, Inc. (the “Company”) and amends and restates the prior Executive Change in Control Severance Benefits Agreement between the Company and Executive dated June 8, 2010 (the “Original Date”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to a qualifying termination of employment in connection with a Change in Control. Certain capitalized terms used in this Agreement are defined in Article 5.
EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT This form of Executive Change in Control Severance Benefits Agreement may be entered into between Onyx Pharmaceuticals, Inc. and each of its Executive Vice Presidents (“EVP”), Senior Vice...Executive Change in Control Severance Benefits Agreement • June 10th, 2008 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Executive Change in Control Severance Benefits Agreement (the “Agreement”) is entered into as of the ___ day of , 20___ (the “Effective Date”), between (“Executive”) and Onyx Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to certain qualifying terminations of employment in connection with a Change in Control. Certain capitalized terms used in this Agreement are defined in Article 5.
EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • February 26th, 2008 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Executive Change in Control Severance Benefits Agreement (the “Agreement”) is entered into as of the 22nd day of February, 2008 (the “Effective Date”), between N. Anthony Coles (“Executive”) and Onyx Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to certain qualifying terminations of employment in connection with a Change in Control. Certain capitalized terms used in this Agreement are defined in Article 5.
